208 related articles for article (PubMed ID: 22092083)
1. Powder X-ray diffraction method for the quantification of cocrystals in the crystallization mixture.
Padrela L; de Azevedo EG; Velaga SP
Drug Dev Ind Pharm; 2012 Aug; 38(8):923-9. PubMed ID: 22092083
[TBL] [Abstract][Full Text] [Related]
2. pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.
Alhalaweh A; Roy L; Rodríguez-Hornedo N; Velaga SP
Mol Pharm; 2012 Sep; 9(9):2605-12. PubMed ID: 22867056
[TBL] [Abstract][Full Text] [Related]
3. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
[TBL] [Abstract][Full Text] [Related]
4. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
Basavoju S; Boström D; Velaga SP
Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
[TBL] [Abstract][Full Text] [Related]
5. Thermal analysis and FTIR spectral curve-fitting investigation of formation mechanism and stability of indomethacin-saccharin cocrystals via solid-state grinding process.
Zhang GC; Lin HL; Lin SY
J Pharm Biomed Anal; 2012 Jul; 66():162-9. PubMed ID: 22497855
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of indomethacin-saccharin cocrystals.
Jung MS; Kim JS; Kim MS; Alhalaweh A; Cho W; Hwang SJ; Velaga SP
J Pharm Pharmacol; 2010 Nov; 62(11):1560-8. PubMed ID: 21039541
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin.
Rahman Z; Samy R; Sayeed VA; Khan MA
Pharm Dev Technol; 2012; 17(4):457-65. PubMed ID: 21265708
[TBL] [Abstract][Full Text] [Related]
8. Effect of sample preparation method on quantification of polymorphs using PXRD.
Alam S; Patel S; Bansal AK
Pharm Dev Technol; 2010; 15(5):452-9. PubMed ID: 19842910
[TBL] [Abstract][Full Text] [Related]
9. Vibrational spectroscopic investigation of polymorphs and cocrystals of indomethacin.
Ali HR; Alhalaweh A; Velaga SP
Drug Dev Ind Pharm; 2013 May; 39(5):625-34. PubMed ID: 22480325
[TBL] [Abstract][Full Text] [Related]
10. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
Bellur Atici E; Karlığa B
J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
[TBL] [Abstract][Full Text] [Related]
11. Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry, X-ray powder diffraction and Raman spectroscopy.
Li Y; Chow PS; Tan RB
Int J Pharm; 2011 Aug; 415(1-2):110-8. PubMed ID: 21645601
[TBL] [Abstract][Full Text] [Related]
12. Preparation, structural analysis, and properties of tenoxicam cocrystals.
Patel JR; Carlton RA; Needham TE; Chichester CO; Vogt FG
Int J Pharm; 2012 Oct; 436(1-2):685-706. PubMed ID: 22841852
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of indomethacin-saccharin (IMC-SAC) co-crystals prepared by an anti-solvent crystallization process.
Chun NH; Wang IC; Lee MJ; Jung YT; Lee S; Kim WS; Choi GJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):854-61. PubMed ID: 23454054
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of electrospray deposition for rapid screening of the cocrystal formation and single step, continuous production of pharmaceutical nanococrystals.
Emami S; Siahi-Shadbad M; Barzegar-Jalali M; Adibkia K
Drug Dev Ind Pharm; 2018 Jun; 44(6):1034-1047. PubMed ID: 29347850
[TBL] [Abstract][Full Text] [Related]
15. Near-infrared spectroscopy for cocrystal screening. A comparative study with Raman spectroscopy.
Allesø M; Velaga S; Alhalaweh A; Cornett C; Rasmussen MA; van den Berg F; de Diego HL; Rantanen J
Anal Chem; 2008 Oct; 80(20):7755-64. PubMed ID: 18798651
[TBL] [Abstract][Full Text] [Related]
16. Dry Mechanochemical Synthesis of Caffeine/Oxalic Acid Cocrystals and Their Evaluation by Powder X-Ray Diffraction and Chemometrics.
Otsuka Y; Ito A; Takeuchi M; Tanaka H
J Pharm Sci; 2017 Dec; 106(12):3458-3464. PubMed ID: 28797789
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
[TBL] [Abstract][Full Text] [Related]
18. Quantification of olanzapine polymorphs using powder X-ray diffraction technique.
Tiwari M; Chawla G; Bansal AK
J Pharm Biomed Anal; 2007 Feb; 43(3):865-72. PubMed ID: 17034979
[TBL] [Abstract][Full Text] [Related]
19. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.
Nijhawan M; Santhosh A; Babu PR; Subrahmanyam CV
Drug Dev Ind Pharm; 2014 Sep; 40(9):1163-72. PubMed ID: 23829186
[TBL] [Abstract][Full Text] [Related]
20. Formation of Indomethacin-Saccharin Cocrystals during Wet Granulation: Role of Polymeric Excipients.
Tanaka R; Duggirala NK; Hattori Y; Otsuka M; Suryanarayanan R
Mol Pharm; 2020 Jan; 17(1):274-283. PubMed ID: 31756100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]